Stay updated on Azacitidine, Venetoclax, Gilteritinib Clinical Trial
Sign up to get notified when there's something new on the Azacitidine, Venetoclax, Gilteritinib Clinical Trial page.

Latest updates to the Azacitidine, Venetoclax, Gilteritinib Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.3.3 was added and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer, indicating minor version housekeeping. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedA new version entry on 2025-12-01 shows an updated Study Status in the record history.SummaryDifference0.3%

- Check39 days agoChange DetectedA new site revision tag (Revision: v3.3.2) appears and the previous revision (Revision: v3.2.0) is removed; there are no changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe top banner notice about government funding status was removed. The rest of the page, including the study history and version list, remains unchanged.SummaryDifference0.6%

- Check60 days agoChange DetectedThe latest version updates the study status and recruitment status in the record history, reflecting ongoing changes in the trial's activity.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded a new date and study status entry; removed an earlier date. Overall, this signals updated tracking/status information without altering core content.SummaryDifference1.0%

Stay in the know with updates to Azacitidine, Venetoclax, Gilteritinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine, Venetoclax, Gilteritinib Clinical Trial page.